• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Agilent Technologies

Agilent Technologies

Agilent Technologies Inc A

Last Price$46.50Day Change (%)-0.23%
Open Price$46.46Day Change ($)-0.10
Day Range46.16–46.7752-Week Range33.12–48.63

As of Mon 9/26/2016 2:19:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Agilent Technologies Prices $300 Million of Senior Notes

    Agilent Technologies Prices $300 Million of Senior Notes

  2. Global Magnetic Resonance Imaging (MRI) Market Research and Analysis 2014-2020 - Key Players are GE Healthcare, Hologic, Emergence Teleradiology, Planmed, Aurora Imaging, Fonar & Agilent Technologies ...

    Global Magnetic Resonance Imaging (MRI) Market Research and Analysis 2014-2020 - Key Players are GE Healthcare, Hologic, Emergence Teleradiology, Planmed, Aurora Imaging, Fonar & Agilent Technologies - Research and Markets

  3. Genome Editing Global Market to Grow 31.1% by 2022 - Increased R&D Expenditure in Biotechnology & Pharmaceutical Industries - Research and Markets

    Genome Editing Global Market to Grow 31.1% by 2022 - Increased R&D Expenditure in Biotechnology & Pharmaceutical Industries - Research and Markets

  4. CBRNE (Chemical, Biological, Radiological, Nuclear And Explosive) Detection Device Markets: Market Strategies and Forecasts, Worldwide, 2016-2022 - Research and Markets

    CBRNE (Chemical, Biological, Radiological, Nuclear And Explosive) Detection Device Markets: Market Strategies and Forecasts, Worldwide, 2016-2022 - Research and Markets

  5. IR Spectroscopy Market Worth USD 1.26 Billion by 2022 - Advancements in Biotechnology & Pharmaceuticals Industries in U.S. - Research and Markets

    IR Spectroscopy Market Worth USD 1.26 Billion by 2022 - Advancements in Biotechnology & Pharmaceuticals Industries in U.S. - Research and Markets

  6. What's the Best Way to Play a Large-Growth Rally?

    You'll be surprised at which funds are poised for a large-growth rebound.

  7. Middle East/Africa: Regional Economic Review – 3Q 2013

    Agilent A reported full-year results indicating respectable revenue growth and continued improvements to profitability. We've updated our model to reflect fiscal 2006 results and are maintaining our fair value estimate. Revenues in the bio-analytical division grew 9% over last year, matching our ...

  8. What the NHL Playoffs Can Teach Investors

    Agilent's A third-quarter gross margin was well ahead of our expectations for the quarter, and the company produced another respectable performance in year-over-year sales (15%) and order (11%) growth. The gross margin finished at 55%, much higher than our assumption for the quarter and 5 ...

  9. Selected American Shares Annual Review 2014

    This report includes candid statements and observations regarding investment strategies, individual securities, and economic and market conditions; however, there is no guarantee that these statements, opinions or forecasts will prove to be correct. Equity markets are volatile and an investor may ...

  10. Semiconductor Industry Outlook – April 2011

    The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.